Edward A. Kesicki - Concepedia

Author

Edward A. Kesicki

Eli Lilly (United States)

Also Known As

E. A. KESICKI, Edward A Kesicki, Edward A. Kesicki, Edward Kesicki

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Infectious Disease Research Institute EKOS Corporation AbbVie (United States)Molecular Oncology (United States)

About

Edward A. Kesicki is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	408
2	Natural Sciences	6	6	697
3	Biochemistry	6	6	694
4	Engineering	2	2	155
5	Health Sciences	1	1	57

Edward A. Kesicki

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome Brian T. Weinert, Takeo Narita, Shankha Satpathy, Cell BiochemistryNatural SciencesMolecular BiologyBiophysicsBroad Scope	2018	511
DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs Eric T. Shinohara, Ling Geng, Jiahui Tan, Cancer Research EngineeringNoncytotoxic Radiation–sensitizing DrugsRadiation EffectRadiation ExposureMolecular Biology	2005	134
Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target Juliane Ollinger, Theresa O’Malley, Edward A. Kesicki, Journal of Bacteriology	2011	130
Phenylboronic Acid−Salicylhydroxamic Acid Bioconjugates. 1. A Novel Boronic Acid Complex for Protein Immobilization Mark L. Stolowitz, Clarence Ahlem, Karin A. Hughes, Bioconjugate Chemistry	2001	115
DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Adam Kashishian, Heather Douangpanya, Darcey Clark, PubMed Tumor BiologyGenome InstabilityOncologyDrug CandidatesChemoprevention Strategy	2003	92
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases Michael R. Michaelides, Arthur F. Kluge, Michael A. Patane, ACS Medicinal Chemistry Letters	2017	72
Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents Edward A. Kesicki, Mai A. Bailey, Yulia Ovechkina, PLoS ONE Anti-tubercular AgentsBioorganic ChemistryPharmacotherapyHeterocycle ChemistryDrug Resistance	2016	57
A Novel Highly Stereoselective Synthesis of 2,3-Disubstituted <i>3H</i>-Quinazoline-4-one Derivatives Paul Zhichkin, Edward A. Kesicki, Jennifer Treiberg, Organic Letters	2007	52
Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979 J. Oluoch Odingo, Theresa O’Malley, Edward A. Kesicki, Medicinal Chemistry 22Medicinal ChemistryBioorganic ChemistryBiochemistryNatural Sciences	2014	52
Synthesis and Postsynthetic Modification of Oligodeoxynucleotides Containing 4-Thio-2'-deoxyuridine (ds4U) Robert S. Coleman, Edward A. Kesicki Journal of the American Chemical Society Molecular SciencesBioorganic ChemistryNucleic Acid ChemistryBiochemistryDonut Icon	1994	50

Page 1